Arcutis Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 12.33 M | $290.42 M | 3.03% | 9.61% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 9.87 M | $232.64 M | 0.00% | 7.70% |
| BLACKROCK, INC. | 05/13/2026 | 9.20 M | $216.76 M | 1.11% | 7.17% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 8.27 M | $194.88 M | 0.00% | 6.45% |
| STATE STREET CORP | 05/15/2026 | 6.30 M | $148.34 M | 14.72% | 4.91% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 5.67 M | $133.51 M | 1.99% | 4.42% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 4.98 M | $117.35 M | -26.30% | 3.88% |
| 05/15/2026 | 4.87 M | $114.77 M | 100.00% | 3.80% | |
| GILDER GAGNON HOWE & CO LLC | 05/15/2026 | 4.30 M | $101.40 M | -3.36% | 3.36% |
| MORGAN STANLEY | 05/15/2026 | 4.22 M | $99.40 M | -2.80% | 3.29% |
| UBS GROUP AG | 05/05/2026 | 3.33 M | $78.44 M | 2.65% | 2.60% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.05 M | $71.76 M | 10.61% | 2.37% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 2.50 M | $58.81 M | -6.96% | 1.95% |
| MARSHALL WACE, LLP | 05/15/2026 | 2.43 M | $57.29 M | 435.36% | 1.90% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 2.30 M | $54.14 M | 20.94% | 1.79% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 2.23 M | $52.45 M | -13.13% | 1.74% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 2.22 M | $52.33 M | 32.74% | 1.73% |
| 05/08/2026 | 1.95 M | $46.05 M | 100.00% | 1.52% | |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 1.85 M | $43.68 M | 1.34% | 1.45% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.60 M | $37.77 M | 1.69% | 1.25% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 1.46 M | $34.47 M | -0.27% | 1.14% |
| OBERWEIS ASSET MANAGEMENT INC/ | 05/15/2026 | 1.37 M | $32.18 M | 68.97% | 1.07% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2026 | 1.36 M | $31.94 M | -0.79% | 1.06% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 1.24 M | $29.32 M | -34.59% | 0.97% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 1.10 M | $26.00 M | 142.06% | 0.86% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.09 M | $25.60 M | 35.30% | 0.85% |
| FEDERATED HERMES, INC. | 05/11/2026 | 1.08 M | $25.38 M | 20.80% | 0.84% |
| BAMCO INC /NY/ | 05/15/2026 | 1.07 M | $25.26 M | 112.44% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.01 M | $23.86 M | -0.22% | 0.79% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 988.39 K | $23.29 M | -2.00% | 0.77% |
| NORTHERN TRUST CORP | 05/14/2026 | 976.51 K | $23.01 M | 2.23% | 0.76% |
| PERPETUAL LTD | 04/14/2026 | 909.55 K | $21.43 M | -0.12% | 0.71% |
| NUVEEN, LLC | 04/30/2026 | 902.13 K | $21.25 M | -34.73% | 0.70% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 812.15 K | $19.13 M | 16.05% | 0.63% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 771.76 K | $18.18 M | 100.00% | 0.60% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 733.97 K | $17.29 M | 38.17% | 0.57% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 724.07 K | $17.06 M | 9.47% | 0.56% |
| ABRDN PLC | 04/29/2026 | 645.07 K | $15.20 M | 10.01% | 0.50% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2026 | 636.20 K | $14.99 M | -29.31% | 0.50% |
| NEARWATER CAPITAL MARKETS, LTD | 05/15/2026 | 607.30 K | $14.31 M | -1.25% | 0.47% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 590.88 K | $13.92 M | 38.98% | 0.46% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 576.58 K | $13.58 M | 32.66% | 0.45% |
| FISHMAN JAY A LTD/MI | 04/29/2026 | 566.73 K | $13.35 M | 0.37% | 0.44% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 540.51 K | $12.73 M | -40.86% | 0.42% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 503.86 K | $11.87 M | 299.95% | 0.39% |
| 05/15/2026 | 500.00 K | $11.78 M | 100.00% | 0.39% | |
| M&G PLC | 05/13/2026 | 469.08 K | $11.26 M | 100.00% | 0.37% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 468.25 K | $11.03 M | -6.24% | 0.37% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 450.00 K | $10.60 M | -10.00% | 0.35% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 448.21 K | $10.56 M | -61.57% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcutis Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 333 institutional investors and hedge funds held shares of Arcutis Biotherapeutics Inc. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 12.33 M
Frazier Life Sciences Management, L.P.: 9.87 M
BlackRock, Inc.: 9.2 M
Rubric Capital Management LP: 8.27 M
STATE STREET CORP: 6.3 M
Polar Capital Holdings Plc: 5.67 M
103.91% of Arcutis Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 144.16 M shares in the last 24 months. This purchase volume represents approximately $3.58 B in transactions.